Ameriprise
IBDQ

Ameriprise’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Ameriprise’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-476,318
Closed -$12M – 4137
2025
Q3 		$12M Sell
476,318
-401,273
-46% -$10.1M ﹤0.01% 1770
2025
Q2 		$22.1M Sell
877,591
-201,942
-19% -$5.07M 0.01% 1288
2025
Q1 		$27.2M Sell
1,079,533
-496,406
-31% -$12.5M 0.01% 1142
2024
Q4 		$39.5M Sell
1,575,939
-77,804
-5% -$1.95M 0.01% 957
2024
Q3 		$41.4M Sell
1,653,743
-50,695
-3% -$1.27M 0.01% 930
2024
Q2 		$42.3M Sell
1,704,438
-3,821
-0.2% -$94.7K 0.01% 878
2024
Q1 		$42.4M Buy
1,708,259
+116,986
+7% +$2.9M 0.01% 884
2023
Q4 		$39M Sell
1,591,273
-450,405
-22% -$11M 0.01% 890
2023
Q3 		$49.7M Buy
2,041,678
+747,584
+58% +$18.2M 0.02% 740
2023
Q2 		$31.5M Buy
1,294,094
+94,659
+8% +$2.32M 0.01% 995
2023
Q1 		$29.4M Sell
1,199,435
-231,920
-16% -$5.67M 0.01% 1020
2022
Q4 		$34.8M Buy
1,431,355
+255,640
+22% +$6.19M 0.01% 893
2022
Q3 		$28.4M Buy
1,175,715
+296,186
+34% +$7.31M 0.01% 964
2022
Q2 		$21.7M Buy
879,529
+389,561
+80% +$9.7M 0.01% 1163
2022
Q1 		$12.4M Buy
489,968
+118,874
+32% +$3.07M ﹤0.01% 1736
2021
Q4 		$9.8M Buy
371,094
+31,138
+9% +$828K ﹤0.01% 1996
2021
Q3 		$9.13M Buy
339,956
+24,633
+8% +$664K ﹤0.01% 1926
2021
Q2 		$8.51M Buy
315,323
+11,832
+4% +$319K ﹤0.01% 2059
2021
Q1 		$8.15M Buy
303,491
+10,098
+3% +$273K ﹤0.01% 2041
2020
Q4 		$8.03M Buy
293,393
+14,135
+5% +$384K ﹤0.01% 1920
2020
Q3 		$7.58M Buy
279,258
+7,287
+3% +$198K ﹤0.01% 1767
2020
Q2 		$7.37M Buy
271,971
+7,195
+3% +$189K ﹤0.01% 1771
2020
Q1 		$6.61M Buy
264,776
+43,543
+20% +$1.12M ﹤0.01% 1703
2019
Q4 		$5.74M Buy
221,233
+4,452
+2% +$115K ﹤0.01% 2154
2019
Q3 		$5.57M Sell
216,781
-83,346
-28% -$2.14M ﹤0.01% 2136
2019
Q2 		$7.69M Buy
300,127
+96,378
+47% +$2.41M ﹤0.01% 1924
2019
Q1 		$5.06M Buy
203,749
+130,949
+180% +$3.18M ﹤0.01% 2222
2018
Q4 		$1.72M Buy
72,800
+5,784
+9% +$137K ﹤0.01% 2715
2018
Q3 		$1.6M Sell
67,016
-7,497
-10% -$180K ﹤0.01% 2892
2018
Q2 		$1.78M Buy
74,513
+2,251
+3% +$53.9K ﹤0.01% 2778
2018
Q1 		$1.75M Buy
72,262
+10,462
+17% +$256K ﹤0.01% 2736
2017
Q4 		$1.55M Buy
61,800
+16,827
+37% +$422K ﹤0.01% 2785
2017
Q3 		$1.13M Buy
44,973
+31,564
+235% +$793K ﹤0.01% 2905
2017
Q2 		$332K Buy
+13,409
New +$334K ﹤0.01% 3380

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameriprise's IBDQ Position: Q4 2025 in Review

Ameriprise sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 476,318 shares — an estimated $12M sold.

Ameriprise first reported a position in IBDQ in Q2 2017 and held it in 34 quarters. The position peaked at $49.7M in Q3 2023. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Ameriprise reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Ameriprise sold 476,318 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $12M.
  • Ameriprise first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2017 and held it in 34 quarters.
  • Ameriprise's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $49.7M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.